メインナビゲーションにスキップ
検索にスキップ
メインコンテンツにスキップ
Keio University ホーム
ヘルプ＆FAQ
English
日本語
ホーム
プロファイル
研究部門
研究成果
専門知識、名前、または所属機関で検索
Scopus著者プロファイル
米澤 淳
薬学科
ウェブサイト
https://k-ris.keio.ac.jp/html/100016565_ja.html
h-index
4395
被引用数
31
h 指数
Pureの文献数とScopusの被引用数に基づいて算出されます
2003
2025
年別の研究成果
概要
フィンガープリント
ネットワーク
研究成果
(132)
類似のプロファイル
(1)
フィンガープリント
Atsushi Yonezawaが活動している研究トピックを掘り下げます。このトピックラベルは、この研究者の研究成果に基づきます。これらがまとまってユニークなフィンガープリントを構成します。
並べ替え順
重み付け
アルファベット順
Pharmacology, Toxicology and Pharmaceutical Science
Pharmacokinetics
100%
Tacrolimus
61%
Cisplatin
51%
Riboflavin
47%
Pharmacodynamics
36%
Organic Cation Transporter
35%
Oxaliplatin
34%
Mouse
33%
Nephrotoxicity
32%
Cations
28%
Infliximab
27%
Fluorouracil
26%
Rheumatoid Arthritis
24%
Adverse Event
22%
Mycophenolic Acid
20%
Acute Kidney Failure
20%
Biosimilar Agent
20%
Warfarin
20%
Etanercept
20%
Antiporter
20%
Monoclonal Antibody
19%
Metformin
19%
Malignant Neoplasm
19%
Hemodialysis
18%
Peripheral Neuropathy
16%
Interstitial Lung Disease
16%
Amino Acid
15%
Retrospective Study
14%
Pharmacotherapy
14%
Gelatin
14%
Disease
14%
Case-Control Study
13%
Syrian Hamster
13%
Colorectal Cancer
13%
Remdesivir
13%
Ciclosporin
13%
Genetic Disorder
13%
Oral Mucositis
13%
Active Metabolite
13%
Itraconazole
13%
Tadalafil
13%
Proton Pump Inhibitor
13%
Somatomedin C
13%
Injury
13%
Pharmacokinetic Modeling
13%
Rituximab
13%
Chemotherapy
13%
Cytotoxicity
12%
Cytochrome P450 3A5
12%
CYP2C19
12%
Keyphrases
Cisplatin
25%
MATE1
21%
Proton-coupled Organic Cation Antiporter
19%
Therapeutic Antibody
17%
Awake Craniotomy
16%
Extrusion
16%
Multidrug
16%
Nephrotoxicity
16%
Tacrolimus
15%
Oxaliplatin
14%
Japanese Patients
14%
Infliximab
14%
Organic Cation Transporter
14%
Pharmacokinetics
13%
MATE2-K
13%
Gelatin Hydrogel
13%
Platinum Agents
13%
Living Donor Liver Transplantation
13%
Rat Cortical Neurons
13%
Riboflavin Deficiency
13%
Liver Transplant Recipients
13%
Biosimilar
13%
5-fluorouracil (5-FU)
13%
Nicotinic Acetylcholine Receptor (nAChR)
13%
GS-441524
13%
Donepezil
13%
Hangeshashinto
13%
Serum Concentration
11%
Metformin
11%
Genotype
11%
Rheumatoid Arthritis
10%
Kidney
10%
Japan
9%
OCT2
9%
Cisplatin Nephrotoxicity
9%
Antibody-drug Conjugate
9%
Therapeutic Drug Monitoring
9%
Cytochrome P450 3A4 (CYP3A4)
9%
Pharmacotherapy
9%
Acetylcholinesterase Inhibitors (AChEI)
8%
In Cancer
8%
Glutamate Excitotoxicity
7%
LC-MS Bioanalysis
7%
Antibody Therapy
7%
Maintenance Hemodialysis Patients
7%
Adult Patients
7%
Neuroprotective Action
7%
Disease Activity
7%
Causal Therapy
7%
Lansoprazole
6%
Medicine and Dentistry
Riboflavin
26%
Cations
20%
Rheumatoid Arthritis
16%
Antiporter
14%
Metabolite
13%
Organic Cation Transporter
13%
Kidney Function
13%
Nephrotoxicity
13%
Liver Graft
13%
Liver Transplantation
13%
Hemodialysis
13%
Stomach Cancer
13%
Recurrent Disease
13%
Riboflavin Deficiency
13%
Cisplatin
13%
Hyperammonemia
13%
Infliximab
13%
Fibroblast Growth Factor 2
11%
Gelatin
11%
Adverse Event
11%
Malignant Neoplasm
10%
Tetrylammonium
10%
Craniotomy
9%
Brown-Vialetto-Van Laere Syndrome
8%
Cancer Therapy
8%
Cancer Chemotherapy
8%
Cytochrome P450 3A5
7%
1 Methyl 4 Phenylpyridinium
7%
Infusion
7%
Cytokine
7%
Retrospective Study
7%
Outpatient
7%
Drug Therapy
7%
Disease Activity
7%
Biological Product
7%
Low Drug Dose
7%
Procainamide
6%
Translational Research
6%
Transcytosis
6%
Anodyne
6%
Oxaliplatin-Induced Peripheral Neuropathy
6%
Fluorouracil
6%
Remifentanil
6%
Osteonecrosis Of The Femoral Head
6%
Kidney Cell
6%
CD137
6%
Critical Limb Ischemia
6%
Sustained Drug Release
6%
Hepatitis C
6%
Kidney Injury
6%
